Western Europe remains at the forefront of evidence-based harm reduction and treatment interventions. The majority of the countries in the region have adopted a health-based strategy towards drug use (including decriminalisation of possession for personal use), and are moving towards more proportionate sentences for drug offences.
The event, which brought together a variety of stakeholders including IDPC chair Mike Trace, was intended to raise awareness among missions in Geneva, civil society and other partners on the importance of public health and human rights in the context of the world drug problem.
This annual national report from Public Health England describes trends in the extent of infections and associated risks and behaviours among people who inject drugs in the UK to the end of 2014 with updated information from November 2015.
The 4th edition of the extended Reitox network will focus on what we know about women using illicit drugs, what the gaps in knowledge are, and what the consequences could be for monitoring the situation and organising responses.
The meeting was an opportunity for the CSF to discuss and draft recommendations on the UNGASS in an effort to feed into the conclusions of the CSTF, and met with members of the HDG to offer guidance on the EU position around the Special Session.
With the aim of enhancing local service provision and seizing the opportunity for progress provided by a new generation of highly effective hepatitis C drugs, this roadshow will focus on showcasing good practice and identifying solutions for tackling hepatitis C.
Drug dealers involved in trafficking that would bring profits of more than 75,000 euros will be sentenced to life imprisonment regardless of the number of people accused, according to a new ruling of the Greek Supreme Court.
This EMCDDA meeting brings together European health professionals and researchers to explore the challenges, needs and best practice around responding to NPS in a variety of health and intervention settings
The EMCDDA has developed a tool that examines and compares the penalties or rehabilitative responses for the core offences of drug use, possession for personal use, and supply-related offences, across European countries.
This innovative initiative lists 16 standards that represent a minimum benchmark of quality for interventions in drug use prevention, risk and harm reduction, treatment, social integration and rehabilitation.